Sterilizable pharmaceutical package for ophthalmic formulations
US-2020171244-A1 · Jun 4, 2020 · US
Ophthalmic solution container
US12285930B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12285930-B2 |
| Application number | US-201917299704-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2019 |
| Priority date | Dec 7, 2018 |
| Publication date | Apr 29, 2025 |
| Grant date | Apr 29, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An ophthalmic solution container has an accommodation part in which an ophthalmic solution is accommodated, and the accommodation part is composed of a laminate having a layer containing a cyclic olefin interpolymer (copolymer) and a layer containing a polyethylene resin provided outside the layer containing the cyclic olefin interpolymer (copolymer). The thickness of the layer containing the cyclic olefin interpolymer (copolymer) is 50 μm to 1,000 μm, and the thickness of the laminate is 300 μm to 2,000 μm. According to the container, it is possible to minimize sorption (adsorption and absorption) of the ophthalmic solution, it is possible to improve moisture barrier properties and minimize evaporation, and it is also possible to reduce the squeeze strength.
First claim
Opening claim text (preview).
What is claimed is: 1. An ophthalmic solution container having an accommodation part in which an ophthalmic solution is accommodated, wherein the accommodation part is composed of a laminate having an innermost layer that does not contain a cyclic olefin interpolymer (copolymer) and contains a polyethylene resin, an intermediate layer containing a cyclic olefin interpolymer (copolymer) provided outside the innermost layer, and an outer layer containing a polyethylene resin provided outside the intermediate layer containing the cyclic olefin interpolymer (copolymer), wherein a thickness of the intermediate layer containing the cyclic olefin interpolymer (copolymer) is 50 μm to 1,000 μm, a thickness of the outer layer containing a polyethylene resin is 350 μm to 1,400 μm, a thickness of the innermost layer is 162 μm or less, and a thickness of the laminate is 500 μm to 2,000 μm. 2. The ophthalmic solution container according to claim 1 , wherein the thickness of the intermediate layer containing the cyclic olefin interpolymer (copolymer) is 69 μm to 181 μm, and the thickness of the outer layer containing a polyethylene resin is 359 μm to 480 μm. 3. The ophthalmic solution container according to claim 1 , wherein the ophthalmic solution container has a nozzle part for instilling an ophthalmic solution accommodated in the accommodation part. 4. The ophthalmic solution container according to any one of claim 1 , wherein the intermediate layer containing the cyclic olefin interpolymer (copolymer) contains at least one of a COP (a copolymer of different cyclic olefins) or a COC (a copolymer of a cyclic olefin and an acyclic olefin).
Assignees
Inventors
Classifications
Layered products having a non-planar shape · CPC title
adapted to discharge drops · CPC title
- B65D1/0215Primary
multilayered (B65D81/3837 takes precedence) · CPC title
Medical packaging · CPC title
Dimensional properties · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12285930B2 cover?
- An ophthalmic solution container has an accommodation part in which an ophthalmic solution is accommodated, and the accommodation part is composed of a laminate having a layer containing a cyclic olefin interpolymer (copolymer) and a layer containing a polyethylene resin provided outside the layer containing the cyclic olefin interpolymer (copolymer). The thickness of the layer containing the c…
- Who is the assignee on this patent?
- Fujimori Kogyo Co Ltd, Zacros Corp
- What technology area does this patent fall under?
- Primary CPC classification B65D1/0215. Mapped technology areas include Operations & Transport.
- When was this patent published?
- Publication date Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).